agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
115.66
+5.36 (4.86%)
At close: Nov 13, 2026, 4:00 PM EST
115.65
-0.01 (-0.01%)
After-hours: Nov 13, 2026, 7:47 PM EST

agilon health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-87.1-391.35-260.15-262.6-106.55-406.49
Depreciation & Amortization
13.6614.8913.969.848.9510.48
Other Amortization
13.713.710.56.2--
Loss (Gain) From Sale of Assets
-14-143.7847.55--0.47
Asset Writedown & Restructuring Costs
36.0936.093.6---
Loss (Gain) on Equity Investments
29.891.84-11.65-16.49-10.726.94
Stock-Based Compensation
58.4749.1250.6669.528.38292.39
Other Operating Activities
1.79-5.520.94-4.253.75-0.18
Change in Accounts Receivable
344.59344.59-74.58-460.37-204.17-149.04
Change in Accounts Payable
-85.59-85.594.6432.1165.7419.36
Change in Other Net Operating Assets
-310.73-69.53200.53418.197974.66
Operating Cash Flow
-4.23-105.76-57.78-156.2-130.81-148.16
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-12.77-13.24-13.25-15.83-15.43-6.56
Cash Acquisitions
----45.25--
Divestitures
---2.190.5-1.34
Sale (Purchase) of Intangibles
-7.68-29.87-28.03-14.99-17.24-6.86
Investment in Securities
101.03133.72194.9149.38-405.727.1
Investing Cash Flow
79.5988.61139.89-44.02-444.39-90.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----100
Long-Term Debt Repaid
---3.75-5-5-119.9
Net Debt Issued (Repaid)
-3.5--3.75-5-5-19.9
Issuance of Common Stock
4.47-1.1711.8733.061,189
Repurchase of Common Stock
----200--
Other Financing Activities
-1.63-2.99----14.74
Financing Cash Flow
-0.66-2.99-2.58-193.1328.061,154

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
74.7-20.1579.53-393.35-547.14915.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-17.01-119.01-71.03-172.03-146.23-154.72
Free Cash Flow Growth
------
Free Cash Flow Margin
-0.28%-2.01%-1.17%-3.99%-6.12%-10.17%
Free Cash Flow Per Share
-1.02-7.19-4.32-10.52-8.96-10.37
Levered Free Cash Flow
-120.64-81.23-35.88-64.4-131.384.09
Unlevered Free Cash Flow
-116.34-77.08-32.02-60.24-128.577.94

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
5.725.664.65.83.674.82
Cash Income Tax Paid
1.460.581.85.45.311.82
Change in Working Capital
-51.73189.47130.59-10.07-59.44-55.03
SEC Filings: 10-K · 10-Q